Scott Dreyer

CIK: 0001746251

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)13 (54.2%)

Position reduction

Option Exercises (M)3 (12.5%)

Derivative conversions

Awards (A)4 (16.7%)

Compensation grants

Other (G, F, J, C, D, …)4 (16.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

COLL

COLLEGIUM PHARMACEUTICAL, INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (24 total)

COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 3, 2026
Sale(S)
Direct
3.6K shares at avg. $40.99$146K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 3, 2026
Sale(S)
Direct
46.4K shares at avg. $40.36$1.9M
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Award(A)
Direct
19K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Tax Payment(F)
Direct
21.6K shares at avg. $46.75$1.0M
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Tax Payment(F)
Direct
10K shares at avg. $46.75$466K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2026
Award(A)
Direct
30.7K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Dec 8, 2025
Sale(S)
Direct
11.1K shares at avg. $47.89$533K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Dec 8, 2025
Sale(S)
Direct
6.5K shares at avg. $48.66$315K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Dec 8, 2025
Exercise(M)
Direct
17.6K shares at avg. $15.90$280K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Aug 18, 2025
Exercise(M)
Direct
16.4K shares at avg. $21.34$350K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Aug 18, 2025
Sale(S)
Direct
16.4K shares at avg. $38.21$626K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Aug 13, 2025
Exercise(M)
Direct
4.9K shares at avg. $21.34$104K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Aug 13, 2025
Sale(S)
Direct
4.9K shares at avg. $38.03$185K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 21, 2025
Sale(S)
Direct
18.9K shares at avg. $30.03$567K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 20, 2025
Sale(S)
Direct
1.9K shares at avg. $30.00$58K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 14, 2025
Sale(S)
Direct
2.3K shares at avg. $30.00$68K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 11, 2025
Sale(S)
Direct
15.4K shares at avg. $30.00$462K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 7, 2025
Sale(S)
Direct
2.3K shares at avg. $30.00$70K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 6, 2025
Sale(S)
Direct
15.4K shares at avg. $30.00$462K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Mar 6, 2025
Sale(S)
Direct
3.3K shares at avg. $30.00$99K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Award(A)
Direct
45K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Award(A)
Direct
26.4K shares-
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Tax Payment(F)
Direct
8K shares at avg. $30.52$243K
COLL
COLLEGIUM PHARMACEUTICAL, INC
Feb 10, 2025
Tax Payment(F)
Direct
21.7K shares at avg. $30.52$661K

		Type	Shares	Price		Ownership
Mar 3, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	3,559	$40.99	$145,879	Direct
Mar 3, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	46,417	$40.36	$1,873,557	Direct
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	19,023	-	$0	Direct
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	21,615	$46.75	$1,010,501	Direct
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	9,977	$46.75	$466,425	Direct
Feb 10, 2026	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	30,702	-	$0	Direct
Dec 8, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	11,125	$47.89	$532,771	Direct
Dec 8, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	6,475	$48.66	$315,085	Direct
Dec 8, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Exercise(M)	17,600	$15.90	$279,840	Direct
Aug 18, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Exercise(M)	16,389	$21.34	$349,741	Direct
Aug 18, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	16,389	$38.21	$626,171	Direct
Aug 13, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Exercise(M)	4,861	$21.34	$103,734	Direct
Aug 13, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	4,861	$38.03	$184,881	Direct
Mar 21, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	18,881	$30.03	$566,983	Direct
Mar 20, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	1,927	$30.00	$57,811	Direct
Mar 14, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	2,255	$30.00	$67,661	Direct
Mar 11, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	15,387	$30.00	$461,672	Direct
Mar 7, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	2,348	$30.00	$70,446	Direct
Mar 6, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	15,387	$30.00	$461,672	Direct
Mar 6, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Sale(S)	3,295	$30.00	$98,854	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	45,016	-	-	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Award(A)	26,411	-	-	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	7,953	$30.52	$242,726	Direct
Feb 10, 2025	COLL COLLEGIUM PHARMACEUTICAL, INC	Tax Payment(F)	21,670	$30.52	$661,368	Direct

1-24 of 24 transactions

About Dreyer Scott

Dreyer Scott (SEC CIK 0001746251) files insider reports with the SEC as EVP & Chief Commercial Officer of COLLEGIUM PHARMACEUTICAL, INC (COLL).

Signal8 holds 11 ownership filings by Dreyer Scott, all Form 4s, filed between Feb 12, 2025 and Mar 5, 2026. Those filings report 24 transactions, from Feb 10, 2025 to Mar 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Dreyer Scott's filings is in STOUGHTON, MA.

Recent filings by Dreyer Scott

Mar 3, 2026: Open-market sales of COLL shares (2 lines, Form 4, code S).
Feb 10, 2026: Grant or award of COLL shares (Form 4, code A).
Feb 10, 2026: Tax withholdings of COLL shares (2 lines, Form 4, code F).
Feb 10, 2026: Grant or award of COLL shares (Form 4, code A).
Dec 8, 2025: Open-market sales of COLL shares (2 lines, Form 4, code S).

Other insiders filing for COLLEGIUM PHARMACEUTICAL, INC (COLL)

SANTINI GINO, Director
Freund John Gordon, Director
Lurker Nancy, Director
Paya Carlos V, Director
Glancy Donovan Michael, Director
BOHLIN GAREN G, Director

How to read Form 4 transaction codes